Supplementary Information
Supplemental Methods: Participant recruitment and testing sites, eligibility criteria, blood sampling, calculation of total haemoglobin mass and normal plasma volumes Table S1 : Surgical specialty for planned surgical procedure Table S2 : Characteristics and aetiology of inflammatory bowel disease patients Table S3 : Characteristics, medications and aetiology of liver disease patients. Table S4 : Characteristics, medications and aetiology of chronic heart failure patients. Table S5 : Relationship between total haemoglobin mass and haemoglobin concentration in sub-groups based on plasma volume status.
Participant recruitment and testing sites
Patients were recruited from those managed at University College Hospital (University College London Hospitals NHS Foundation Trust, UCLH), Southampton General Hospital (University Hospital Southampton NHS Foundation Trust) and the Royal Free Hospital (Royal Free London NHS Foundation Trust, RFH). Supplementary Figure 1 shows a Consolidated Standards of Reporting Trials (CONSORT)-style flow diagram indicating included and excluded patients and specific sub-groups. HV, patients with IBD and those awaiting surgery were recruited from and tested at UCLH only. Patients with CLD were recruited from and tested at all three sites, and those with CHF at UCLH and Southampton. Healthy volunteers were members of staff at UCLH or University College London (UCL) recruited by word of mouth or email advertisement. Patients were identified and recruited at outpatient clinics or when attending other routine clinical appointments.
Eligibility criteria
Inclusion criteria for all participants were, age >18 years, and ability give informed consent and to comply with basic breath-holding instructions. Healthy volunteers were additionally free from known chronic disease or use of regular medications. In CHF PV values were adjusted for age, sex, weight, and height using a published formula to calculate normal volumes as derived from >100,000 measurements of height and weight from Metropolitan Life tables. 6 Normal PV was classified as measured volumes within ± 8% of the expected normal volume on an individual level. Mild to moderate volume expansion was considered >8% to ≤25% positive deviation from expected norms, and severe as >25% above the expected normal volume. 6 
Supplementary references
Supplementary Figure 1 . Consolidated Standards of Reporting Trials (CONSORT)-style flow diagram indicating included and excluded patients and specific sub-groups. Excluded patients are those who declined participation, failed to respond to correspondence via letter and telephone contact or could not be contacted despite multiple attempts by the research team.
Eligible patients approached for inclusion n= 499
Chronic liver disease n= 16
Excluded n= 390
Patients included for analysis n= 109
Surgical n= 28
Healthy volunteers n= 21
Chronic heart failure n= 21
Inflammatory bowel disease n= 22 
